Viatris | Salgsomkostninger Og Administration



Selling And Administration Expenses Lave om Dato
Adcock Ingram Holdings ZAR 997.56M 6.08M 2024-06
Celltrion KRW 239.71B 17.94B 2024-09
Cspc Pharmaceutical CNY 2.1B 22.82M 2024-09
Dianthus Therapeutics USD 6.54M 530K 2024-09
Ecofibre AUD 8.03M 1.38M 2024-06
Kangmei Pharma CNY 245.26M 66.07M 2024-09
Knight Therapeutics CAD 25.48M 119K 2024-09
Laboratorios Farma EUR 32.57M 26.69M 2024-06
Malin Corporation EUR 700K 1.6M 2024-06
Medical Developments International AUD 7.07M 15.4M 2024-06
Neuren Pharmaceuticals AUD 2.33M 47K 2024-12
Organigram Holdings CAD 17.19M 2.88M 2024-12
Pharma Mar EUR 13.23M 2.55M 2024-12
Qiagen NV USD 141.71M 1.05M 2024-12
Sartorius EUR 216.7M 8.5M 2024-09
Sino Biopharmaceutical CNY 3.42B 1.2B 2024-06
Tilray USD 72.38M 4.99M 2024-11
Viatris USD 882.7M 14.8M 2024-12
Zz Pientze Pharmaceu 168.44M 20.66M 2024-09



Viatris Salgsomkostninger Og Administration - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.